R+D COLLABORATIONS

Drive novel cancer diagnostic and therapeutic development through identification of microbial targets

For pharma, biotech, and academic institutions looking to identify, validate, and commercialize microbiome-based data in cancer care, MicrobiomeDX helps lead discovery efforts in investigating microbial targets for diagnostic and therapeutic applications.

platform grapics
DATA GENERATION + ANALYSIS SERVICES

Identify therapeutic response indicators and gut health microbial markers in cancer research

For pharma, biotech, clinical, and academic clients exploring patients’ and cohorts’ microbiome profiles for pre- and clinical studies.  MicrobiomeDX is a CLIA lab delivering data-generation and analyses using our BacProTM pipeline built by leading cancer and microbiome experts.

service grapics